Many docs unfamiliar with chemo-risks
“This is really a problem created by our successes,” said Dr Michael Link, president of the American Society of Clinical Oncology. The findings underscore the need for better communication between cancer specialists and primary-care doctors.
For the study, Dr Larissa Nekhlyudov of Harvard Medical School surveyed 1072 primary-care doctors and 1130 cancer specialists. The doctors were asked which of five side effects they had observed most often in their practices or seen reported for doxorubicin, paclitaxel, oxaliplatin and cyclophosphamide.
The researchers found that only six percent of primary-care doctors were able to identify the main long term side effects of all four of the chemotherapy drugs.
According to Dr Nekhlyudov, the finding was not a surprise, but it underscores the need for better communication between cancer specialists and primary care doctors.
Most oncologists surveyed were able to correctly identify these same late effects, although there was also need for improvement among these specialists’ knowledge of the late effects which ranged from 62% to 97% for the four drugs.
Source: Reuters Health
Author
Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Many docs unfamiliar with chemo-risks
by Health-e News, Health-e News
June 4, 2012